American Research & Management Company’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-124
Closed -$7K 332
2018
Q1
$7K Hold
124
﹤0.01% 312
2017
Q4
$7K Hold
124
﹤0.01% 313
2017
Q3
$7K Hold
124
﹤0.01% 286
2017
Q2
$7K Hold
124
﹤0.01% 282
2017
Q1
$6K Hold
124
﹤0.01% 279
2016
Q4
$6K Hold
124
﹤0.01% 298
2016
Q3
$6K Hold
124
﹤0.01% 303
2016
Q2
$6K Hold
124
﹤0.01% 287
2016
Q1
$6K Hold
124
﹤0.01% 299
2015
Q4
$6K Hold
124
﹤0.01% 299
2015
Q3
$6K Hold
124
﹤0.01% 307
2015
Q2
$7K Hold
124
﹤0.01% 303
2015
Q1
$7K Hold
124
﹤0.01% 307
2014
Q4
$6K Hold
124
﹤0.01% 307
2014
Q3
$6K Hold
124
﹤0.01% 315
2014
Q2
$6K Hold
124
﹤0.01% 324
2014
Q1
$6K Hold
124
﹤0.01% 325
2013
Q4
$5K Hold
124
﹤0.01% 337
2013
Q3
$5K Hold
124
﹤0.01% 323
2013
Q2
$5K Buy
+124
New +$4.73K ﹤0.01% 320

Other funds holding IXJ

American Research & Management Company's IXJ Position: Q2 2018 in Review

American Research & Management Company sold out of iShares Global Healthcare ETF (IXJ) in Q2 2018, closing a stake of 124 shares — an estimated $7K sold.

American Research & Management Company first reported a position in IXJ in Q2 2013 and held it in 20 quarters. The position peaked at $7K in Q1 2018. 165 funds tracked by Wall St. Rank hold IXJ as of Q2 2018.

  • American Research & Management Company reported no remaining iShares Global Healthcare ETF position as of Q2 2018 after selling out during the quarter.
  • American Research & Management Company sold 124 iShares Global Healthcare ETF shares in Q2 2018, an estimated $7K.
  • American Research & Management Company first reported a position in iShares Global Healthcare ETF in Q2 2013 and held it in 20 quarters.
  • American Research & Management Company's iShares Global Healthcare ETF position peaked at $7K in Q1 2018.
  • 165 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2018.

Based on American Research & Management Company's 13F filing for Q2 2018, filed 25 Jul 2018.